Format

Send to

Choose Destination
Pediatr Infect Dis J. 2011 Jun;30(6):510-7. doi: 10.1097/INF.0b013e3182184ae7.

Epidemiology and prevention of respiratory syncytial virus infections among infants and young children.

Author information

1
Division of Viral Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. fez7@cdc.gov

Abstract

Since its discovery in 1956, respiratory syncytial virus (RSV) has been recognized as one of the most common causes of serious lower respiratory tract infections in young children worldwide. While considered a high priority, development of a safe and effective vaccine has remained elusive. Prevention of RSV disease relies on infection control and hygiene measures, as well as providing immunoprophylaxis in select infants. The prophylaxis, however, is costly, and so targeting the recipient population and timing of administration is important for optimal effectiveness and judicious use of limited health care resources. This article reviews the epidemiology of RSV infections in infants and young children, including risk factors for severe disease, so as to inform decisions about prevention efforts.

PMID:
21487331
DOI:
10.1097/INF.0b013e3182184ae7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center